BrightSpring Health Services, Inc. Operating Cash Flow
BrightSpring Health Services, Inc. (BTSG) reported Operating Cash Flow of $166.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-31
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $43.92M, a 10.51% decline year-over-year.
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $122.94M, a 21.01% increase year-over-year.
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $231.56M, a 155.55% increase year-over-year.
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $107.94M, a 296.15% increase year-over-year.
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $490.17M, a 1961.79% increase from fiscal 2024.
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $23.77M, a 88.72% decline from fiscal 2023.
- BrightSpring Health Services, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $210.78M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $43.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $166.86M 10-Q · filed 2026-07-31 | $398.42M derived: sum of 3 quarters · filed 2026-07-31 | $506.35M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $122.94M 10-Q · filed 2026-05-01 | $354.50M derived: sum of 2 quarters · filed 2026-05-01 | $462.44M derived: sum of 3 quarters · filed 2026-05-01 | $511.51M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $231.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $339.50M derived: sum of 2 quarters · filed 2026-02-27 | $388.57M derived: sum of 3 quarters · filed 2026-07-31 | $490.17M 10-K · filed 2026-02-27 |
| 2025-09-30 | $107.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $157.01M derived: sum of 2 quarters · filed 2026-07-31 | $258.61M 10-Q · filed 2025-10-28 | $349.22M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $49.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $150.67M 10-Q · filed 2026-07-31 | $241.29M derived: sum of 3 quarters · filed 2026-07-31 | $268.53M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $101.60M 10-Q · filed 2026-05-01 | $192.21M derived: sum of 2 quarters · filed 2026-05-01 | $219.46M derived: sum of 3 quarters · filed 2026-05-01 | $204.23M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $90.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $117.86M derived: sum of 2 quarters · filed 2026-02-27 | $102.63M derived: sum of 3 quarters · filed 2026-02-27 | $23.77M 10-K · filed 2026-02-27 |
| 2024-09-30 | $27.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $12.02M derived: sum of 2 quarters · filed 2025-10-28 | -$66.84M 10-Q · filed 2025-10-28 | $95.56M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$15.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$94.08M 10-Q · filed 2025-08-01 | $68.32M derived: sum of 3 quarters · filed 2026-02-27 | $102.01M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$78.86M 10-Q · filed 2025-05-02 | $83.54M derived: sum of 2 quarters · filed 2026-02-27 | $117.23M derived: sum of 3 quarters · filed 2026-02-27 | $92.03M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $162.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $196.09M derived: sum of 2 quarters · filed 2026-02-27 | $170.89M derived: sum of 3 quarters · filed 2026-02-27 | $210.78M 10-K · filed 2026-02-27 |
| 2023-09-30 | $33.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $8.49M derived: sum of 2 quarters · filed 2024-11-01 | $48.38M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | -$25.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $14.69M 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $39.90M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$4.65M 8-K · filed 2025-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |